Volker Adams

10.9k total citations · 1 hit paper
170 papers, 8.1k citations indexed

About

Volker Adams is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Volker Adams has authored 170 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 86 papers in Cardiology and Cardiovascular Medicine and 43 papers in Complementary and alternative medicine. Recurrent topics in Volker Adams's work include Cardiovascular Function and Risk Factors (46 papers), Cardiovascular and exercise physiology (43 papers) and Muscle Physiology and Disorders (36 papers). Volker Adams is often cited by papers focused on Cardiovascular Function and Risk Factors (46 papers), Cardiovascular and exercise physiology (43 papers) and Muscle Physiology and Disorders (36 papers). Volker Adams collaborates with scholars based in Germany, United States and Norway. Volker Adams's co-authors include Gerhard Schüler, Rainer Hambrecht, Axel Linke, Karsten Lenk, Sandra Erbs, T. Scott Bowen, Stephan Gielen, Axel Linke, Sven Möbius‐Winkler and Jiangtao Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Volker Adams

164 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations

2012 568 citations Marco Guazzi, Volker Adams et al. Circulation profile →

Peers

Countries citing papers authored by Volker Adams

Since Specialization

Citations

This map shows the geographic impact of Volker Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Adams more than expected).

Fields of papers citing papers by Volker Adams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Adams. The network helps show where Volker Adams may publish in the future.

Co-authorship network of co-authors of Volker Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Adams. A scholar is included among the top collaborators of Volker Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Adams. Volker Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction 2024 ·European Journal of Pharmacology ·(unknown), (unknown), Volker Adams, Anselmo Sigari Moriscot, Siegfried Labeit	3
2	Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF 2024 ·Cells ·(unknown), Antje Schauer, Antje Augstein, (unknown), (unknown), Peggy Barthel, (unknown), Anselmo Sigari Moriscot, Axel Linke, Volker Adams	6
3	Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain 2024 ·Circulation Heart Failure ·Antje Schauer, Volker Adams, (unknown), (unknown), Antje Augstein, Peggy Barthel, (unknown), Gunar Fabig, (unknown), (unknown), Ali El‐Armouche, Thomas Müller‐Reichert, Axel Linke, Ephraim B. Winzer	13
4	Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Antje Schauer, Antje Augstein, (unknown), Peggy Barthel, Norman Mangner, Siegfried Labeit, T. Scott Bowen, Axel Linke, Volker Adams	2
5	Comparison of exercise training modalities and change in peak oxygen consumption in heart failure with preserved ejection fraction: a secondary analysis of the OptimEx-Clin trial 2024 ·European Journal of Preventive Cardiology ·Stephan Mueller, (unknown), (unknown), Ephraim B. Winzer, Andreas B. Gevaert, Paul Beckers, Bernhard Haller, Frank Edelmann, Jeffrey W. Christle, Mark J. Haykowsky, Vandana Sachdev, Dalane W. Kitzman, Axel Linke, Volker Adams, Ulrik Wisløff, Burkert Pieske, Emeline M. Van Craenenbroeck, Martin Halle	5
6	Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF 2023 ·Frontiers in Cardiovascular Medicine ·Norman Mangner, Ephraim B. Winzer, Axel Linke, Volker Adams	5
7	Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx Trial 2022 ·Circulation Heart Failure ·Ephraim B. Winzer, Antje Augstein, Antje Schauer, Stephan Mueller, (unknown), (unknown), Jennifer Hommel, Emeline M. Van Craenenbroeck, Ulrik Wisløff, Burkert Pieske, Martin Halle, Axel Linke, Volker Adams	18
8	Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model 2022 ·International Journal of Molecular Sciences ·Ephraim B. Winzer, Antje Schauer, (unknown), Antje Augstein, (unknown), (unknown), Peggy Barthel, Anett Jannasch, Siegfried Labeit, Norman Mangner, Axel Linke, Volker Adams	21
9	The Potential Role of Plasma miR-155 and miR-206 as Circulatory Biomarkers in Inflammatory Cardiomyopathy 2021 ·ESC Heart Failure ·Danilo Obradović, Karl‐Philipp Rommel, Stephan Blazek, Karin Klingel, Matthias Gutberlet, Christian Lücke, Petra Büttner, Hölger Thiele, Volker Adams, Philipp Lurz, Fabian Emrich, Christian Besler	17
10	miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial 2021 ·European Journal of Preventive Cardiology ·Andreas B. Gevaert, (unknown), Amaryllis H. Van Craenenbroeck, Steven Van Laere, (unknown), Caroline M. Van De Heyning, Evgeny Belyavskiy, Stephan Mueller, Ephraim B. Winzer, André Duvinage, Frank Edelmann, Paul Beckers, Hein Heidbüchel, Ulrik Wisløff, Burkert Pieske, Volker Adams, Martin Halle, Emeline M. Van Craenenbroeck, (unknown)	18
11	Structural and functional alterations in heart and skeletal muscle following severe TAC in mice: impact of moderate exercise training 2021 ·Biological Research ·(unknown), Sarah Werner, Volker Adams, (unknown), (unknown), Hölger Thiele, Petra Büttner	6
12	Spatio-temporal regulation of calpain activity after experimental myocardial infarction in vivo 2021 ·Biochemistry and Biophysics Reports ·Kun Zhang, (unknown), (unknown), David M. Poitz, Christian Pfluecke, Frank R. Heinzel, Burkert Pieske, Volker Adams, Antje Schauer, (unknown), Ruth H. Strasser, Axel Linke, Silvio Quick, Felix M. Heidrich	6
13	Regulation of Glucose Metabolism by MuRF1 and Treatment of Myopathy in Diabetic Mice with Small Molecules Targeting MuRF1 2021 ·International Journal of Molecular Sciences ·Siegfried Labeit, Stephanie Hirner, Julius Bogomolovas, (unknown), (unknown), Anselmo Sigari Moriscot, T. Scott Bowen, Volker Adams	15
14	Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy 2020 ·Cells ·Volker Adams, (unknown), Sergey Zozulya, (unknown), Anselmo Sigari Moriscot, Axel Linke, Siegfried Labeit	22
15	Emerging Strategies Targeting Catabolic Muscle Stress Relief 2020 ·International Journal of Molecular Sciences ·(unknown), Volker Adams, Siegfried Labeit, T. Scott Bowen	12
16	Endomyocardial miR-133a Levels Correlate with Myocardial Inflammation, Improved Left Ventricular Function, and Clinical Outcome in Patients with Inflammatory Cardiomyopathy 2016 ·European Journal of Heart Failure ·Christian Besler, Daniel J. Urban, Stefan Watzka, David J. Lang, Karl‐Philipp Rommel, Reinhard Kandolf, Karin Klingel, Hölger Thiele, Axel Linke, Gerhard Schüler, Volker Adams, Philipp Lurz	64
17	Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. EACPR/AHA Joint Scientific Statement 2012 ·European Heart Journal ·Daniel E. Forman, Carl J. Lavie, Dalane W. Kitzman, Marco Guazzi, Alessandro Mezzani, Luc Vanhees, Viviane M. Conraads, Martin Halle, Volker Adams, (unknown), Ross Arena, Gerald F. Fletcher	8
18	Endothelial Progenitor Cells and Exercise-Induced Redox Regulation 2010 ·Antioxidants and Redox Signaling ·Sven Moebius‐Winkler, Gerhard Schüler, Volker Adams	17
19	Abstract 1048: Chronic Heart Failure and Aging: Effects of Exercise Training on Left Ventricular Diastolic Dysfunction 2009 ·Circulation ·Marcus Sandri, Stephan Gielen, Norman Mangner, Volker Adams, Robert Höllriegel, Sandra Erbs, Axel Linke, Sven Möbius‐Winkler, Rainer Hambrecht, Gerhard Schüler	1
20	Impact of Exercise Training on Myostatin Expression in the Myocardium and Skeletal Muscle in a Chronic Heart Failure Model 2009 ·European Journal of Heart Failure ·Karsten Lenk, (unknown), Axel Linke, Sandra Erbs, Yasuharu Matsumoto, Volker Adams, Gerhard Schüler	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact